Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Pharma & Healthcare > Blood Anticoagulant- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Blood Anticoagulant- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Blood Anticoagulant- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published: 2025-02-07

Pages: 94 Pages

Report ld: 3669326

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for Blood Anticoagulant was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Anticoagulant, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blood Anticoagulant by region & country, by Type, and by Application.

The Blood Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Anticoagulant.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Blood Anticoagulant- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  • Market Size Available for Years

  • 2025-2031

  • Global Blood Anticoagulant Companies Covered

  • Bayer

    Boehringer Ingelheim

    Bristol-Myers Squibb

    Daiichi Sankyo

    Pfizer

    Johnson & Johnson

    Sanofi

    AstraZeneca

    Eli Lilly

    Keryx Biopharmaceuticals

  • Global Blood Anticoagulant Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Blood Anticoagulant Market, Segment by Type

  • Oral

    Injection

  • Global Blood Anticoagulant Market, Segment by Application

  • Hospital

    Clinic

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Blood Anticoagulant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Blood Anticoagulant in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Blood Anticoagulant Product Introduction
    1.2 Global Blood Anticoagulant Market Size Forecast
        1.2.1 Global Blood Anticoagulant Sales Value (2020-2031)
        1.2.2 Global Blood Anticoagulant Sales Volume (2020-2031)
        1.2.3 Global Blood Anticoagulant Sales Price (2020-2031)
    1.3 Blood Anticoagulant Market Trends & Drivers
        1.3.1 Blood Anticoagulant Industry Trends
        1.3.2 Blood Anticoagulant Market Drivers & Opportunity
        1.3.3 Blood Anticoagulant Market Challenges
        1.3.4 Blood Anticoagulant Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Blood Anticoagulant Players Revenue Ranking (2024)
    2.2 Global Blood Anticoagulant Revenue by Company (2020-2025)
    2.3 Global Blood Anticoagulant Players Sales Volume Ranking (2024)
    2.4 Global Blood Anticoagulant Sales Volume by Company Players (2020-2025)
    2.5 Global Blood Anticoagulant Average Price by Company (2020-2025)
    2.6 Key Manufacturers Blood Anticoagulant Manufacturing Base and Headquarters
    2.7 Key Manufacturers Blood Anticoagulant Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Blood Anticoagulant
    2.9 Blood Anticoagulant Market Competitive Analysis
        2.9.1 Blood Anticoagulant Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by Blood Anticoagulant Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Anticoagulant as of 2024)
    2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oral
        3.1.2 Injection
    3.2 Global Blood Anticoagulant Sales Value by Type
        3.2.1 Global Blood Anticoagulant Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Blood Anticoagulant Sales Value, by Type (2020-2031)
        3.2.3 Global Blood Anticoagulant Sales Value, by Type (%) (2020-2031)
    3.3 Global Blood Anticoagulant Sales Volume by Type
        3.3.1 Global Blood Anticoagulant Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global Blood Anticoagulant Sales Volume, by Type (2020-2031)
        3.3.3 Global Blood Anticoagulant Sales Volume, by Type (%) (2020-2031)
    3.4 Global Blood Anticoagulant Average Price by Type (2020-2031)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Others
    4.2 Global Blood Anticoagulant Sales Value by Application
        4.2.1 Global Blood Anticoagulant Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Blood Anticoagulant Sales Value, by Application (2020-2031)
        4.2.3 Global Blood Anticoagulant Sales Value, by Application (%) (2020-2031)
    4.3 Global Blood Anticoagulant Sales Volume by Application
        4.3.1 Global Blood Anticoagulant Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global Blood Anticoagulant Sales Volume, by Application (2020-2031)
        4.3.3 Global Blood Anticoagulant Sales Volume, by Application (%) (2020-2031)
    4.4 Global Blood Anticoagulant Average Price by Application (2020-2031)
5 Segmentation by Region
    5.1 Global Blood Anticoagulant Sales Value by Region
        5.1.1 Global Blood Anticoagulant Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Blood Anticoagulant Sales Value by Region (2020-2025)
        5.1.3 Global Blood Anticoagulant Sales Value by Region (2026-2031)
        5.1.4 Global Blood Anticoagulant Sales Value by Region (%), (2020-2031)
    5.2 Global Blood Anticoagulant Sales Volume by Region
        5.2.1 Global Blood Anticoagulant Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global Blood Anticoagulant Sales Volume by Region (2020-2025)
        5.2.3 Global Blood Anticoagulant Sales Volume by Region (2026-2031)
        5.2.4 Global Blood Anticoagulant Sales Volume by Region (%), (2020-2031)
    5.3 Global Blood Anticoagulant Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America Blood Anticoagulant Sales Value, 2020-2031
        5.4.2 North America Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe Blood Anticoagulant Sales Value, 2020-2031
        5.5.2 Europe Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific Blood Anticoagulant Sales Value, 2020-2031
        5.6.2 Asia Pacific Blood Anticoagulant Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America Blood Anticoagulant Sales Value, 2020-2031
        5.7.2 South America Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Blood Anticoagulant Sales Value, 2020-2031
        5.8.2 Middle East & Africa Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Blood Anticoagulant Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Blood Anticoagulant Sales Value
        6.2.1 Key Countries/Regions Blood Anticoagulant Sales Value, 2020-2031
        6.2.2 Key Countries/Regions Blood Anticoagulant Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States Blood Anticoagulant Sales Value, 2020-2031
        6.3.2 United States Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Blood Anticoagulant Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Blood Anticoagulant Sales Value, 2020-2031
        6.4.2 Europe Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Blood Anticoagulant Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Blood Anticoagulant Sales Value, 2020-2031
        6.5.2 China Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Blood Anticoagulant Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Blood Anticoagulant Sales Value, 2020-2031
        6.6.2 Japan Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Blood Anticoagulant Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Blood Anticoagulant Sales Value, 2020-2031
        6.7.2 South Korea Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Blood Anticoagulant Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Blood Anticoagulant Sales Value, 2020-2031
        6.8.2 Southeast Asia Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Blood Anticoagulant Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Blood Anticoagulant Sales Value, 2020-2031
        6.9.2 India Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Blood Anticoagulant Sales Value by Application, 2024 VS 2031
7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Company Information
        7.1.2 Bayer Introduction and Business Overview
        7.1.3 Bayer Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Bayer Blood Anticoagulant Product Offerings
        7.1.5 Bayer Recent Development
    7.2 Boehringer Ingelheim
        7.2.1 Boehringer Ingelheim Company Information
        7.2.2 Boehringer Ingelheim Introduction and Business Overview
        7.2.3 Boehringer Ingelheim Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Boehringer Ingelheim Blood Anticoagulant Product Offerings
        7.2.5 Boehringer Ingelheim Recent Development
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Company Information
        7.3.2 Bristol-Myers Squibb Introduction and Business Overview
        7.3.3 Bristol-Myers Squibb Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Bristol-Myers Squibb Blood Anticoagulant Product Offerings
        7.3.5 Bristol-Myers Squibb Recent Development
    7.4 Daiichi Sankyo
        7.4.1 Daiichi Sankyo Company Information
        7.4.2 Daiichi Sankyo Introduction and Business Overview
        7.4.3 Daiichi Sankyo Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Daiichi Sankyo Blood Anticoagulant Product Offerings
        7.4.5 Daiichi Sankyo Recent Development
    7.5 Pfizer
        7.5.1 Pfizer Company Information
        7.5.2 Pfizer Introduction and Business Overview
        7.5.3 Pfizer Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Pfizer Blood Anticoagulant Product Offerings
        7.5.5 Pfizer Recent Development
    7.6 Johnson & Johnson
        7.6.1 Johnson & Johnson Company Information
        7.6.2 Johnson & Johnson Introduction and Business Overview
        7.6.3 Johnson & Johnson Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Johnson & Johnson Blood Anticoagulant Product Offerings
        7.6.5 Johnson & Johnson Recent Development
    7.7 Sanofi
        7.7.1 Sanofi Company Information
        7.7.2 Sanofi Introduction and Business Overview
        7.7.3 Sanofi Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Sanofi Blood Anticoagulant Product Offerings
        7.7.5 Sanofi Recent Development
    7.8 AstraZeneca
        7.8.1 AstraZeneca Company Information
        7.8.2 AstraZeneca Introduction and Business Overview
        7.8.3 AstraZeneca Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 AstraZeneca Blood Anticoagulant Product Offerings
        7.8.5 AstraZeneca Recent Development
    7.9 Eli Lilly
        7.9.1 Eli Lilly Company Information
        7.9.2 Eli Lilly Introduction and Business Overview
        7.9.3 Eli Lilly Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 Eli Lilly Blood Anticoagulant Product Offerings
        7.9.5 Eli Lilly Recent Development
    7.10 Keryx Biopharmaceuticals
        7.10.1 Keryx Biopharmaceuticals Company Information
        7.10.2 Keryx Biopharmaceuticals Introduction and Business Overview
        7.10.3 Keryx Biopharmaceuticals Blood Anticoagulant Sales, Revenue, Price and Gross Margin (2020-2025)
        7.10.4 Keryx Biopharmaceuticals Blood Anticoagulant Product Offerings
        7.10.5 Keryx Biopharmaceuticals Recent Development
8 Industry Chain Analysis
    8.1 Blood Anticoagulant Industrial Chain
    8.2 Blood Anticoagulant Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Blood Anticoagulant Sales Model
        8.5.2 Sales Channel
        8.5.3 Blood Anticoagulant Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Blood Anticoagulant Market Trends
 Table 2. Blood Anticoagulant Market Drivers & Opportunity
 Table 3. Blood Anticoagulant Market Challenges
 Table 4. Blood Anticoagulant Market Restraints
 Table 5. Global Blood Anticoagulant Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Blood Anticoagulant Revenue Market Share by Company (2020-2025)
 Table 7. Global Blood Anticoagulant Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global Blood Anticoagulant Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Blood Anticoagulant Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers Blood Anticoagulant Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Blood Anticoagulant Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Blood Anticoagulant
 Table 13. Global Blood Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Anticoagulant as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Blood Anticoagulant Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Blood Anticoagulant Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Blood Anticoagulant Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Blood Anticoagulant Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Blood Anticoagulant Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Blood Anticoagulant Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global Blood Anticoagulant Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global Blood Anticoagulant Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global Blood Anticoagulant Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Blood Anticoagulant Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Blood Anticoagulant Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global Blood Anticoagulant Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global Blood Anticoagulant Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Blood Anticoagulant Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Blood Anticoagulant Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Blood Anticoagulant Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Blood Anticoagulant Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Blood Anticoagulant Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global Blood Anticoagulant Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global Blood Anticoagulant Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global Blood Anticoagulant Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Blood Anticoagulant Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Blood Anticoagulant Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global Blood Anticoagulant Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global Blood Anticoagulant Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Blood Anticoagulant Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Blood Anticoagulant Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Blood Anticoagulant Sales Value by Region (2020-2025) & (%)
 Table 44. Global Blood Anticoagulant Sales Value by Region (2026-2031) & (%)
 Table 45. Global Blood Anticoagulant Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global Blood Anticoagulant Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global Blood Anticoagulant Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global Blood Anticoagulant Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Blood Anticoagulant Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Blood Anticoagulant Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global Blood Anticoagulant Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions Blood Anticoagulant Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Blood Anticoagulant Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Blood Anticoagulant Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Blood Anticoagulant Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions Blood Anticoagulant Sales Volume, (2026-2031) & (K Units)
 Table 57. Bayer Company Information
 Table 58. Bayer Introduction and Business Overview
 Table 59. Bayer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. Bayer Blood Anticoagulant Product Offerings
 Table 61. Bayer Recent Development
 Table 62. Boehringer Ingelheim Company Information
 Table 63. Boehringer Ingelheim Introduction and Business Overview
 Table 64. Boehringer Ingelheim Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. Boehringer Ingelheim Blood Anticoagulant Product Offerings
 Table 66. Boehringer Ingelheim Recent Development
 Table 67. Bristol-Myers Squibb Company Information
 Table 68. Bristol-Myers Squibb Introduction and Business Overview
 Table 69. Bristol-Myers Squibb Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. Bristol-Myers Squibb Blood Anticoagulant Product Offerings
 Table 71. Bristol-Myers Squibb Recent Development
 Table 72. Daiichi Sankyo Company Information
 Table 73. Daiichi Sankyo Introduction and Business Overview
 Table 74. Daiichi Sankyo Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Daiichi Sankyo Blood Anticoagulant Product Offerings
 Table 76. Daiichi Sankyo Recent Development
 Table 77. Pfizer Company Information
 Table 78. Pfizer Introduction and Business Overview
 Table 79. Pfizer Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Pfizer Blood Anticoagulant Product Offerings
 Table 81. Pfizer Recent Development
 Table 82. Johnson & Johnson Company Information
 Table 83. Johnson & Johnson Introduction and Business Overview
 Table 84. Johnson & Johnson Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Johnson & Johnson Blood Anticoagulant Product Offerings
 Table 86. Johnson & Johnson Recent Development
 Table 87. Sanofi Company Information
 Table 88. Sanofi Introduction and Business Overview
 Table 89. Sanofi Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Sanofi Blood Anticoagulant Product Offerings
 Table 91. Sanofi Recent Development
 Table 92. AstraZeneca Company Information
 Table 93. AstraZeneca Introduction and Business Overview
 Table 94. AstraZeneca Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. AstraZeneca Blood Anticoagulant Product Offerings
 Table 96. AstraZeneca Recent Development
 Table 97. Eli Lilly Company Information
 Table 98. Eli Lilly Introduction and Business Overview
 Table 99. Eli Lilly Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Eli Lilly Blood Anticoagulant Product Offerings
 Table 101. Eli Lilly Recent Development
 Table 102. Keryx Biopharmaceuticals Company Information
 Table 103. Keryx Biopharmaceuticals Introduction and Business Overview
 Table 104. Keryx Biopharmaceuticals Blood Anticoagulant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. Keryx Biopharmaceuticals Blood Anticoagulant Product Offerings
 Table 106. Keryx Biopharmaceuticals Recent Development
 Table 107. Key Raw Materials Lists
 Table 108. Raw Materials Key Suppliers Lists
 Table 109. Blood Anticoagulant Downstream Customers
 Table 110. Blood Anticoagulant Distributors List
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources


List of Figures
 Figure 1. Blood Anticoagulant Product Picture
 Figure 2. Global Blood Anticoagulant Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Blood Anticoagulant Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Blood Anticoagulant Sales Volume (2020-2031) & (K Units)
 Figure 5. Global Blood Anticoagulant Sales Price (2020-2031) & (US$/Unit)
 Figure 6. Blood Anticoagulant Report Years Considered
 Figure 7. Global Blood Anticoagulant Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Blood Anticoagulant Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Anticoagulant Revenue in 2024
 Figure 10. Blood Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Oral Picture
 Figure 12. Injection Picture
 Figure 13. Global Blood Anticoagulant Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Blood Anticoagulant Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Blood Anticoagulant Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 16. Global Blood Anticoagulant Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Blood Anticoagulant Price by Type (2020-2031) & (US$/Unit)
 Figure 18. Product Picture of Hospital
 Figure 19. Product Picture of Clinic
 Figure 20. Product Picture of Others
 Figure 21. Global Blood Anticoagulant Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Blood Anticoagulant Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Blood Anticoagulant Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 24. Global Blood Anticoagulant Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Blood Anticoagulant Price by Application (2020-2031) & (US$/Unit)
 Figure 26. North America Blood Anticoagulant Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Blood Anticoagulant Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Blood Anticoagulant Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Blood Anticoagulant Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Blood Anticoagulant Sales Volume (%), (2020-2031)
 Figure 38. United States Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Blood Anticoagulant Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Blood Anticoagulant Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Blood Anticoagulant Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Blood Anticoagulant Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Blood Anticoagulant Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Blood Anticoagulant Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Blood Anticoagulant Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Blood Anticoagulant Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Blood Anticoagulant Sales Value by Application (%), 2024 VS 2031
 Figure 59. Blood Anticoagulant Industrial Chain
 Figure 60. Blood Anticoagulant Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description

The global market for Blood Anticoagulant was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Anticoagulant, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blood Anticoagulant by region & country, by Type, and by Application.

The Blood Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Anticoagulant.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Blood Anticoagulant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Blood Anticoagulant in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

Blood Anticoagulant- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published: 2025-02-07

Pages: 94 Pages

Report ld: 3669326

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Offline

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now